Product Images Beizray
View Photos of Packaging, Labels & Appearance
- albumin-final - albumin final
- figure-1 - figure 1
- figure-10 - figure 10
- figure-2 - figure 2
- figure-3 - figure 3
- figure-4 - figure 4
- figure-5 - figure 5
- figure-6 - figure 6
- figure-7 - figure 7
- figure-8 - figure 8
- figure-9 - figure 9
- kit-label-9-27 - kit label 9 27
- kit-pic - kit pic
- structure - structure
- vial-label-9-29 - vial label 9 29
Product Label Images
The following 15 images provide visual information about the product associated with Beizray NDC 83513-009 by Zhuhai Beihai Biotech Co., Ltd., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
albumin-final - albumin final
figure-1 - figure 1
figure-10 - figure 10
figure-2 - figure 2
This is a table showing the survival probability in percentage over different time intervals measured in months. The survival probability starts at 100% and decreases as the time in months increases from 6 to 48.*
figure-3 - figure 3
This description provides information on cumulative probability, overall survival rate with a Log-rank p-value of 0.010, and survival time in months. The text seems to be related to analyzing survival data or outcomes in a research study or clinical trial.*
figure-4 - figure 4
figure-5 - figure 5
figure-6 - figure 6
figure-7 - figure 7
figure-8 - figure 8
figure-9 - figure 9
kit-label-9-27 - kit label 9 27
This text appears to be a detailed description of a medication named BEIZRAY (docetaxel) injection. It provides information such as dosage, administration instructions, recommended storage conditions, and precautions. The medication is available in vials containing 80 mg of docetaxel in 4 mL solution (20 mg/mL) for intravenous use. The text also mentions the NDC code, color-coding with corresponding hexadecimal values, and warnings about the hazardous nature of the drug. It emphasizes the correct preparation and administration process, specifying the use of 0.9% Sodium Chloride injection solution for dilution. Overall, this text serves as essential information for healthcare professionals regarding the proper usage of BEIZRAY in intravenous infusion.*
kit-pic - kit pic
structure - structure
vial-label-9-29 - vial label 9 29
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
